hg_58610.1

Basic information about the TSS

---

TSS ID: hg_58610.1 Species: human Chr: chr5		Start: 134738541 End: 134738561 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000297156.4 BC130325 AK313156 Distance: 0 GeneID: 819 HGNC/MGI_ID: HGNC:1471 UniProt_ID: P49069

Gene_name: calcium modulating ligand Gene_symbol: CAMLG Gene_synonyms: CAML GET2 Gene_source: HGNC:1471

TATA-Box annotation

---

Distance to TSS:	3
Nearest PromoterID:	NM_001745
Entrez ID:	819
Nearest Unigene:	Hs.529846
Nearest Refseq:	NM_001745
Nearest Ensembl:	ENSG00000164615
Gene Name:	calcium modulating ligand
Gene Alias:	CAML|GET2
Gene Description:	calcium modulating ligand
Gene Type:	protein-coding
CpG%:	0.125
GC%:	0.716418
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CAMLG p2@CAMLG
Sample		p1@CAMLG	p2@CAMLG
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	50.65	3.51
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	53.21	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	52.66	1.93
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	48.03	2.49
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	47.47	3.37
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	46.51	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	62.31	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	45.78	3.63
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	47.66	2.99
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	47.53	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	34.76	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	38.62	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	49.49	4.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	46.76	2.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	49.84	3.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	55.58	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	43.03	3.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	54.84	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	47.45	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	48.59	3.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	53.19	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	53.00	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	48.08	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	56.30	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	53.40	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	57.29	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	57.69	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	42.44	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	48.30	3.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.79	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	45.85	3.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	42.98	3.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	40.52	3.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	33.81	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	37.40	4.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	45.41	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	38.01	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	35.06	3.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	42.68	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	38.65	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	31.52	3.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	29.57	3.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	30.58	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	33.04	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	34.13	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	31.64	5.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	24.23	3.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	36.36	4.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.32	4.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	27.09	4.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	35.66	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	36.25	3.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	21.65	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	28.83	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	18.46	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.72	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	26.58	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	30.83	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	32.69	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.04	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	16.82	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	17.52	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	26.50	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	22.74	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	23.43	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.14	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.34	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	20.17	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	21.86	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	22.58	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	23.54	3.97
Adipocyte - breast, donor1	11376-118A8	34.84	3.17
Adipocyte - breast, donor2	11327-117E4	25.03	3.85
Adipocyte - omental, donor1	11473-119C6	30.53	4.83
Adipocyte - omental, donor2	11474-119C7	14.95	5.23
Adipocyte - omental, donor3	11475-119C8	21.77	2.68
Adipocyte - perirenal, donor1	11476-119C9	19.78	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	26.65	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	64.82	3.13
Adipocyte differentiation, day04, donor1	13019-139D4	44.39	7.82
Adipocyte differentiation, day04, donor2	13022-139D7	32.43	2.83
Adipocyte differentiation, day04, donor3	13025-139E1	34.57	4.74
Adipocyte differentiation, day04, donor4	13028-139E4	39.38	5.29
Adipocyte differentiation, day08, donor1	13020-139D5	23.81	5.95
Adipocyte differentiation, day08, donor2	13023-139D8	37.12	3.87
Adipocyte differentiation, day08, donor3	13026-139E2	27.19	5.87
Adipocyte differentiation, day08, donor4	13029-139E5	35.06	3.90
Adipocyte differentiation, day12, donor1	13021-139D6	22.04	6.24
Adipocyte differentiation, day12, donor2	13024-139D9	21.85	3.01
Adipocyte differentiation, day12, donor3	13027-139E3	21.60	4.25
Adipocyte differentiation, day12, donor4	13030-139E6	19.49	2.74
Alveolar Epithelial Cells, donor1	11510-119G7	24.75	2.43
Alveolar Epithelial Cells, donor2	11590-120G6	6.81	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	22.31	2.70
Amniotic Epithelial Cells, donor2	11613-122A2	28.45	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	26.30	3.70
Anulus Pulposus Cell, donor1	11248-116E6	72.43	5.95
Anulus Pulposus Cell, donor2	11463-119B5	44.33	6.86
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	31.90	4.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	52.10	4.78
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	47.09	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	30.49	2.99
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	35.41	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	42.24	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	31.19	2.92
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	47.09	2.91
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	46.92	4.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	35.78	3.39
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.03	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	42.63	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	37.89	3.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	44.63	4.22
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	31.61	4.29
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.34	3.40
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	40.89	2.14
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	35.12	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	32.84	4.31
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	33.62	4.80
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	29.85	4.97
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	33.49	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	35.29	2.66
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	54.51	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	34.20	5.13
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	35.06	5.56
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	36.91	2.84
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	32.84	2.82
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	35.37	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	47.80	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	39.19	3.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	28.30	2.41
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	41.58	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.97	5.09
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	30.82	4.08
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	38.76	5.72
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	30.64	4.32
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	31.54	3.81
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	31.03	2.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	31.02	3.56
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	41.69	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	33.88	3.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	43.32	3.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	33.53	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	34.25	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	55.42	5.08
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.65	2.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	41.31	4.28
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	35.85	2.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	31.71	3.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	45.77	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	37.66	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	29.92	4.24
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	30.53	1.45
Astrocyte - cerebellum, donor1	11500-119F6	20.76	4.91
Astrocyte - cerebellum, donor2	11580-120F5	17.80	3.42
Astrocyte - cerebellum, donor3	11661-122F5	19.30	3.57
Astrocyte - cerebral cortex, donor1	11235-116D2	41.48	5.93
Astrocyte - cerebral cortex, donor2	11316-117D2	33.16	6.63
Astrocyte - cerebral cortex, donor3	11392-118C6	44.30	6.56
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	37.04	3.90
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	27.06	4.76
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	28.79	2.84
Basophils, donor1	12241-129G9	51.00	7.32
Basophils, donor2	12242-129H1	78.29	10.10
Basophils, donor3	12243-129H2	41.60	8.82
Bronchial Epithelial Cell, donor1	11511-119G8	17.03	4.74
Bronchial Epithelial Cell, donor2	11591-120G7	5.94	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	5.65
Bronchial Epithelial Cell, donor5	11457-119A8	8.11	2.70
Bronchial Epithelial Cell, donor6	11461-119B3	15.43	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	24.29	3.96
Burkitt's lymphoma cell line:DAUDI	10422-106C8	162.52	5.36
Burkitt's lymphoma cell line:RAJI	10476-106I8	103.64	6.06
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	90.50	9.27
CD133+ stem cells - cord blood derived, pool1	12223-129E9	227.52	31.03
CD14+ Monocytes, donor1	11224-116B9	42.83	5.07
CD14+ Monocytes, donor2	11305-117B9	33.78	4.08
CD14+ Monocytes, donor3	11381-118B4	45.88	7.46
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	28.59	10.19
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.91	3.79
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.23	6.57
CD14+ monocytes - mock treated, donor1	11863-125A9	30.36	5.64
CD14+ monocytes - mock treated, donor2	11873-125C1	22.93	4.22
CD14+ monocytes - mock treated, donor3	11883-125D2	26.30	5.21
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	21.43	2.68
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	23.18	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.31	2.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.88	1.76
CD14+ monocytes - treated with BCG, donor2	11870-125B7	18.34	3.56
CD14+ monocytes - treated with BCG, donor3	11880-125C8	25.03	3.48
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.33	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	22.71	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	31.06	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	26.77	2.68
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	19.56	3.19
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	29.77	2.91
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	17.62	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.91	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	17.46	3.93
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	23.67	5.11
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	28.26	3.14
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	23.15	3.79
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.02	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	15.50	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	12.28	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	19.36	2.27
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	21.19	3.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	29.96	2.59
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	17.61	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.76	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	19.49	2.78
CD14+CD16+ Monocytes, donor1	11789-124B7	35.53	5.89
CD14+CD16+ Monocytes, donor2	11801-124D1	32.80	4.39
CD14+CD16+ Monocytes, donor3	11912-125G4	29.46	4.77
CD14+CD16- Monocytes, donor1	11788-124B6	45.63	6.23
CD14+CD16- Monocytes, donor2	11799-124C8	44.01	3.84
CD14+CD16- Monocytes, donor3	11910-125G2	41.25	5.35
CD14-CD16+ Monocytes, donor1	11790-124B8	38.02	5.87
CD14-CD16+ Monocytes, donor2	11800-124C9	31.18	7.03
CD14-CD16+ Monocytes, donor3	11911-125G3	33.48	8.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	75.20	8.13
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	61.70	14.24
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	53.85	13.46
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	79.42	11.19
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	90.06	12.33
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	57.56	14.74
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	61.18	12.55
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	85.69	25.05
CD19+ B Cells, donor1	11544-120B5	70.68	17.26
CD19+ B Cells, donor2	11624-122B4	71.09	17.41
CD19+ B Cells, donor3	11705-123B4	65.63	14.14
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	20.20	6.46
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	21.57	4.39
CD34+ Progenitors, donor1	11545-120B6	92.37	14.06
CD34+ Progenitors, donor2	11625-122B5	71.35	8.99
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	65.76	11.65
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	70.35	7.22
CD4+ T Cells, donor1	11225-116C1	141.75	35.35
CD4+ T Cells, donor2	11306-117C1	132.88	29.39
CD4+ T Cells, donor3	11382-118B5	108.27	28.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	43.65	10.46
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	49.86	7.64
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	51.74	11.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	110.46	23.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	96.92	17.56
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	72.52	13.18
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	50.15	8.82
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	44.06	8.13
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	38.37	8.54
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	95.94	15.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	96.78	12.93
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	67.32	12.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.48	7.17
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	37.40	9.97
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	39.09	7.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	106.87	19.58
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	109.33	23.05
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	77.11	12.55
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	58.60	8.53
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	38.77	6.28
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	43.08	8.41
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	93.03	15.67
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	84.92	16.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	73.22	21.79
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	83.14	16.83
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	81.24	17.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	73.98	22.33
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	58.43	17.45
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	50.06	15.46
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	73.92	16.94
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	68.76	18.26
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	81.71	19.39
CD8+ T Cells, donor1	11226-116C2	117.21	15.71
CD8+ T Cells, donor2	11307-117C2	101.37	20.27
CD8+ T Cells, donor3	11383-118B6	114.88	28.53
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.71	2.06
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	19.41	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.24	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	24.92	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	22.08	2.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	24.79	1.82
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.03	3.04
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.16	2.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	24.62	3.05
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	26.26	3.32
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	25.27	3.78
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	27.44	3.20
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	52.09	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	48.73	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	45.50	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.13	2.52
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	27.05	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.04	1.89
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	25.67	3.80
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.99	2.15
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	20.84	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	28.68	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	32.32	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.23	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	53.00	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.96	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	59.10	4.01
Cardiac Myocyte, donor1	11525-119I4	21.93	5.48
Cardiac Myocyte, donor2	11605-120I3	45.46	2.47
Cardiac Myocyte, donor3	11686-122I3	34.73	5.26
Chondrocyte - de diff, donor1	11261-116G1	23.23	1.39
Chondrocyte - de diff, donor2	11338-117F6	49.04	3.91
Chondrocyte - de diff, donor3	11410-118E6	69.63	6.03
Chondrocyte - re diff, donor2	11339-117F7	33.12	6.27
Chondrocyte - re diff, donor3	11411-118E7	44.08	7.28
Ciliary Epithelial Cells, donor1	11242-116D9	45.79	6.77
Ciliary Epithelial Cells, donor2	11323-117D9	31.21	3.85
Ciliary Epithelial Cells, donor3	11399-118D4	37.88	5.58
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	46.22	18.71
Corneal Epithelial Cells, donor1	11526-119I5	10.32	1.54
Corneal Epithelial Cells, donor2	11606-120I4	5.69	2.28
Corneal Epithelial Cells, donor3	11687-122I4	10.74	2.81
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	13.70	2.97
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	18.61	2.84
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.71	4.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	42.36	13.32
Dendritic Cells - plasmacytoid, donor2	11309-117C4	44.40	13.06
Dendritic Cells - plasmacytoid, donor3	11385-118B8	26.62	15.49
Endothelial Cells - Aortic, donor0	11207-116A1	25.35	3.17
Endothelial Cells - Aortic, donor1	11263-116G3	24.64	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	28.56	2.55
Endothelial Cells - Aortic, donor3	11412-118E8	30.28	2.36
Endothelial Cells - Artery, donor1	11264-116G4	17.45	3.49
Endothelial Cells - Artery, donor2	11341-117F9	23.53	3.76
Endothelial Cells - Artery, donor3	11413-118E9	23.84	2.28
Endothelial Cells - Lymphatic, donor1	11236-116D3	54.75	5.10
Endothelial Cells - Lymphatic, donor2	11317-117D3	45.64	5.48
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.08	3.66
Endothelial Cells - Microvascular, donor1	11265-116G5	15.45	3.27
Endothelial Cells - Microvascular, donor2	11342-117G1	22.39	2.08
Endothelial Cells - Microvascular, donor3	11414-118F1	26.66	3.40
Endothelial Cells - Thoracic, donor1	11266-116G6	36.81	4.00
Endothelial Cells - Thoracic, donor2	11343-117G2	16.25	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	53.30	4.47
Endothelial Cells - Umbilical vein, donor2	11324-117E1	44.76	4.13
Endothelial Cells - Umbilical vein, donor3	11400-118D5	42.01	5.50
Endothelial Cells - Vein, donor1	11267-116G7	14.79	2.28
Endothelial Cells - Vein, donor2	11344-117G3	18.16	2.10
Endothelial Cells - Vein, donor3	11416-118F3	39.09	3.14
Eosinophils, donor1	12244-129H3	91.48	15.25
Eosinophils, donor2	12245-129H4	151.82	28.05
Eosinophils, donor3	12246-129H5	74.90	17.83
Esophageal Epithelial Cells, donor1	11507-119G4	17.10	1.71
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	44.34	8.62
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	27.04	3.07
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	33.37	2.49
Fibroblast - Aortic Adventitial, donor1	11245-116E3	32.99	2.79
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	16.65	3.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	32.91	4.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	13.70	2.11
Fibroblast - Aortic Adventitial, donor3	11401-118D6	24.58	4.32
Fibroblast - Cardiac, donor1	11268-116G8	26.31	2.72
Fibroblast - Cardiac, donor2	11345-117G4	21.22	1.52
Fibroblast - Cardiac, donor3	11417-118F4	22.55	3.00
Fibroblast - Cardiac, donor4	11452-119A3	44.86	7.27
Fibroblast - Cardiac, donor5	11456-119A7	33.00	4.06
Fibroblast - Cardiac, donor6	11460-119B2	23.95	3.64
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.73	5.49
Fibroblast - Choroid Plexus, donor2	11572-120E6	51.77	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	24.90	5.86
Fibroblast - Conjunctival, donor1	11531-120A1	20.53	3.00
Fibroblast - Conjunctival, donor3	11692-122I9	122.96	6.11
Fibroblast - Dermal, donor1	11269-116G9	48.13	4.46
Fibroblast - Dermal, donor2	11346-117G5	29.24	2.36
Fibroblast - Dermal, donor3	11418-118F5	63.59	4.11
Fibroblast - Dermal, donor4	11450-119A1	23.63	2.94
Fibroblast - Dermal, donor5	11454-119A5	27.91	3.31
Fibroblast - Dermal, donor6	11458-119A9	25.99	2.76
Fibroblast - Gingival, donor1	11237-116D4	52.89	3.96
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	44.80	4.45
Fibroblast - Gingival, donor2	11318-117D4	40.46	2.90
Fibroblast - Gingival, donor3	11394-118C8	61.69	4.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	35.32	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	40.35	5.81
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	28.84	2.34
Fibroblast - Gingival, donor6 (control)	11922-125H5	32.32	4.19
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.70	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	33.20	4.83
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	27.27	3.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	27.09	3.95
Fibroblast - Gingival, donor9 (control)	11927-125I1	63.54	7.19
Fibroblast - Lung, donor1	11270-116H1	8.16	0.00
Fibroblast - Lung, donor2	11347-117G6	43.27	1.49
Fibroblast - Lung, donor3	11419-118F6	35.24	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	15.83	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	12.59	0.84
Fibroblast - Mammary, donor1	11540-120B1	45.47	4.47
Fibroblast - Mammary, donor2	11620-122A9	23.97	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	46.75	2.33
Fibroblast - Periodontal Ligament, donor2	11319-117D5	43.38	3.79
Fibroblast - Periodontal Ligament, donor3	11395-118C9	35.49	6.12
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	18.32	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	31.59	2.16
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	43.84	6.49
Fibroblast - Pulmonary Artery, donor1	11250-116E8	24.10	2.54
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	25.20	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	29.40	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	54.56	3.16
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	13.69	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	44.40	5.15
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	36.07	2.96
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	12.94	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	26.02	4.10
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	11.14	2.53
Fibroblast - skin normal, donor1	11553-120C5	34.78	3.28
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	14.64	2.81
Fibroblast - skin normal, donor2	11561-120D4	18.69	3.52
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	10.88	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	54.26	4.56
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	35.56	4.96
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	13.47	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.30	3.73
Fibroblast - skin walker warburg, donor1	11554-120C6	22.27	2.02
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	23.21	4.39
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	29.63	6.10
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	28.43	3.12
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	22.38	3.64
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	21.72	6.39
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	99.52	4.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	72.74	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	82.44	5.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	55.70	6.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	43.84	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	70.14	4.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.41	7.67
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.75	4.24
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	91.10	5.75
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	79.56	5.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	71.92	4.80
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	49.43	3.22
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	64.05	3.72
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	66.72	3.46
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	44.73	2.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	57.04	4.11
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	60.79	4.98
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	49.18	3.28
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	66.78	5.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	69.62	3.81
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	44.46	3.57
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	65.33	4.64
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	60.90	4.24
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	44.25	4.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	63.47	4.79
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	66.26	3.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	66.50	7.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.84	4.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.27	2.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	76.54	4.33
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	88.31	6.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	50.53	5.34
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	74.29	5.07
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	99.75	6.27
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	48.63	4.70
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	107.12	6.41
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	69.83	5.31
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	55.52	3.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	52.00	3.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	54.46	5.54
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	72.67	5.49
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	50.50	5.05
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	39.53	3.70
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	39.04	4.28
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	33.81	3.67
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	38.99	4.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	55.30	3.80
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	65.26	7.19
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	67.11	3.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	61.49	8.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	47.75	4.75
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	61.13	4.64
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	53.63	8.64
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	46.18	4.98
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	76.88	4.78
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	86.33	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	78.86	7.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	85.05	4.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	57.65	5.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	84.14	22.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	60.73	5.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	44.93	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	57.38	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	50.45	3.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	57.24	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	54.25	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	54.26	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	53.69	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	60.75	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	64.20	5.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	96.05	14.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	78.46	12.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	48.25	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	83.01	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	57.57	7.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	56.15	5.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	89.56	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	66.89	4.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	80.84	7.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	144.47	10.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	100.17	8.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	68.47	5.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	104.36	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	148.63	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	109.23	12.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	143.96	6.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	117.66	5.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	124.82	9.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	113.32	7.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	129.53	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	147.46	6.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	123.76	9.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	59.69	7.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	61.63	7.76
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	16.63	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	62.16	4.76
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	66.84	7.10
Hep-2 cells mock treated, biol_rep1	11898-125E8	19.15	3.25
Hep-2 cells mock treated, biol_rep2	11899-125E9	20.26	5.57
Hep-2 cells mock treated, biol_rep3	11900-125F1	20.25	4.10
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	17.93	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	16.55	3.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.01	3.01
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.56	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	18.18	3.60
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	21.46	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.74	6.72
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	23.37	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	31.74	4.59
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	19.62	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	30.25	3.85
Hepatocyte, donor1	11523-119I2	23.00	3.63
Hepatocyte, donor2	11603-120I1	30.17	8.62
Hepatocyte, donor3	11684-122I1	14.72	5.52
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	37.20	13.71
Intestinal epithelial cells (polarized), donor1	11246-116E4	37.58	3.50
Iris Pigment Epithelial Cells, donor1	11530-119I9	26.76	5.21
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	12.99	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	12.60	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.86	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.04	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.88	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	11.25	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	11.80	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	9.69	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.01	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.04	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.04	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	13.87	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.05	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	14.80	0.00
Keratinocyte - epidermal, donor1	11272-116H3	13.79	1.31
Keratinocyte - epidermal, donor2	11349-117G8	8.20	0.59
Keratinocyte - epidermal, donor3	11421-118F8	22.24	3.60
Keratinocyte - oral, donor1	11251-116E9	44.50	5.90
Keratocytes, donor1	11527-119I6	27.51	4.13
Keratocytes, donor2	11607-120I5	17.58	4.69
Keratocytes, donor3	11688-122I5	48.02	3.75
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	2.20
Lens Epithelial Cells, donor1	11529-119I8	46.39	2.16
Lens Epithelial Cells, donor2	11609-120I7	47.63	6.11
Lens Epithelial Cells, donor3	11690-122I7	44.30	5.75
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	33.79	3.79
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	42.42	2.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	37.46	2.83
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	33.34	3.76
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.94	5.36
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	27.60	1.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.06	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	28.06	2.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.85	3.38
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	33.62	2.77
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	45.37	3.68
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.15	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	34.84	2.44
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	36.49	2.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	25.82	1.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	31.41	4.93
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.38	2.49
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.90	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	31.27	3.95
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	30.46	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.17	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.86	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	40.66	3.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.64	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	31.62	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	40.83	4.19
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	28.42	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	30.27	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	39.70	2.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.33	1.06
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	32.47	5.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	34.07	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	22.92	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	41.46	3.70
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	33.11	4.69
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.47	2.06
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	39.88	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	43.82	4.26
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	34.71	2.38
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	34.85	3.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	24.24	1.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	17.27	2.18
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	34.38	2.86
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	33.97	4.57
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	18.36	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	29.33	2.85
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	27.15	1.79
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.48	3.28
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	17.64	6.14
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.78	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.62	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.88	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	4.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.10	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	17.84	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	20.58	4.07
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	22.10	3.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	25.66	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	29.40	3.52
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.00	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.29	6.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	20.66	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.00	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	22.14	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	26.64	4.91
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	24.54	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	30.99	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	25.82	4.37
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	26.62	3.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	22.67	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	24.39	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	25.11	2.99
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	20.47	4.98
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	28.28	3.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	26.55	2.58
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.19	3.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.95	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.87	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	15.82	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.24	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	15.68	8.22
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.09	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.92	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	16.27	6.85
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	20.99	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.29	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	18.49	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	20.97	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.57	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	4.71
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	20.37	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	23.26	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	21.15	4.23
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	22.81	2.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.16	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	16.77	4.93
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.12	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	32.90	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	22.71	3.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	29.33	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	21.11	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	26.98	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	24.94	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.04	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.97	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	22.76	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.79	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	21.63	3.36
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.66	3.98
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	20.05	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	23.18	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.62	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.33	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	26.62	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	20.26	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	3.45
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	25.71	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.81	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	11.35	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	21.63	2.91
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	19.58	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	11.69	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	17.19	3.72
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.06	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.09	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	16.97	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.03	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	11.56	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	20.52	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.17	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	10.94	3.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.94	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	22.62	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	4.64
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	0.00
Macrophage - monocyte derived, donor1	11232-116C8	18.92	5.47
Macrophage - monocyte derived, donor2	11313-117C8	8.26	3.67
Macrophage - monocyte derived, donor3	11389-118C3	16.12	3.67
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	22.30	6.90
Mallassez-derived cells, donor2	11929-125I3	20.60	3.64
Mallassez-derived cells, donor3	11930-125I4	21.54	2.08
Mammary Epithelial Cell, donor1	11273-116H4	44.34	2.79
Mammary Epithelial Cell, donor2	11350-117G9	38.51	3.19
Mammary Epithelial Cell, donor3	11422-118F9	17.71	1.50
Mast cell - stimulated, donor1	11487-119E2	75.93	4.75
Mast cell, donor1	11563-120D6	98.08	9.73
Mast cell, donor2	11565-120D8	85.88	11.59
Mast cell, donor3	11566-120D9	74.97	11.71
Mast cell, donor4	11567-120E1	74.82	14.18
Mast cell, expanded and stimulated, donor5	11940-126A5	25.95	6.21
Mast cell, expanded and stimulated, donor8	11942-126A7	46.69	2.33
Mast cell, expanded, donor5	11939-126A4	64.82	8.03
Mast cell, expanded, donor8	11941-126A6	83.68	8.37
Melanocyte - dark, donor1	11502-119F8	43.48	3.78
Melanocyte - dark, donor2	11582-120F7	52.95	3.46
Melanocyte - dark, donor3	11663-122F7	24.92	5.14
Melanocyte - light, donor1	11274-116H5	15.04	2.59
Melanocyte - light, donor2	11351-117H1	13.65	2.73
Melanocyte - light, donor3	11423-118G1	22.55	3.47
Melanocyte, donor1 (MC+1)	12641-134G4	21.03	4.17
Melanocyte, donor2 (MC+2)	12739-135I3	30.39	3.77
Melanocyte, donor3 (MC+3)	12837-137B2	32.68	4.55
Meningeal Cells, donor1	11493-119E8	22.21	3.85
Meningeal Cells, donor2	11573-120E7	27.29	3.52
Meningeal Cells, donor3	11654-122E7	33.66	2.77
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	54.18	5.13
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	40.55	4.33
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	40.90	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	34.73	4.87
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.11	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	28.79	3.08
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.11	5.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	20.87	3.07
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	34.35	4.02
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.59	2.60
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	51.18	5.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	36.50	2.08
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	19.85	4.48
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.42	2.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	43.78	6.57
Mesenchymal stem cells - umbilical, donor0	11214-116A8	38.46	3.63
Mesothelial Cells, donor1	11247-116E5	22.54	6.36
Mesothelial Cells, donor2	12156-128G5	25.02	6.51
Mesothelial Cells, donor3	11402-118D7	19.58	4.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	24.31	8.10
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.16	5.91
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	19.14	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.63	6.51
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.65	2.49
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	24.78	5.76
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.10	2.33
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.65	3.45
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	10.69	3.56
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	4.42
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	17.10	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	17.11	5.26
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.77	3.61
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.22	3.87
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	12.55	4.01
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.22	2.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.06	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.97	1.84
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.15	3.58
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.21	1.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	11.37	1.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.78	1.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	13.14	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.60	2.03
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	13.05	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.82	2.65
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.01	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.21	3.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	4.11
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.52	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.82	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.12	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.92	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	2.78
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	13.33	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.36	2.49
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.96	3.37
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	10.39	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.07	2.33
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.08	2.41
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	11.69	3.34
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.26	3.41
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.13	2.21
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.03	3.11
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.72	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.34	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.28	3.20
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	18.56	5.99
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.84	3.53
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	17.20	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	15.48	4.20
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.93	3.79
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	20.46	4.83
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	12.29	6.15
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	1.96
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.76	5.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	20.76	4.04
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	15.66	3.71
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	19.95	7.15
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.04	4.93
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	26.29	7.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	43.77	9.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	27.04	5.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.04	2.93
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.29	3.51
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	27.26	4.42
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	18.32	5.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	14.96	3.21
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	17.17	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	22.77	4.22
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	14.98	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	20.98	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	19.44	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	22.66	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	68.51	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.10	5.17
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	45.99	5.75
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	21.29	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.05	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	52.66	9.58
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	3.40
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	31.24	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.04	3.77
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	28.59	2.79
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	29.18	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	33.64	3.99
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	36.73	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	55.22	3.25
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	43.75	4.76
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	34.29	2.94
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	45.20	4.37
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	33.42	3.18
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	43.82	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	44.63	5.25
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	33.83	4.23
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	47.62	5.12
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	45.71	4.92
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	53.33	3.68
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	44.35	5.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	42.08	4.48
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	27.81	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	49.46	4.23
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	44.46	3.39
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	54.12	4.51
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	37.34	3.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	36.32	3.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	32.91	3.16
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	23.01	2.38
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	39.93	5.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	48.81	5.68
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.16	3.91
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	36.61	5.23
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	43.87	3.62
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	28.22	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	45.87	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	32.24	5.46
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.44	3.06
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	39.62	5.14
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	34.92	3.98
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	30.49	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	43.29	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.86	2.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	43.28	4.84
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	38.77	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	41.94	6.80
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	10.12
Myoblast, donor1	11241-116D8	34.29	4.47
Myoblast, donor2	11322-117D8	39.70	3.64
Myoblast, donor3	11398-118D3	31.28	5.38
NK T cell leukemia cell line:KHYG-1	10777-110G3	99.09	4.23
Natural Killer Cells, donor1	11230-116C6	91.33	15.38
Natural Killer Cells, donor2	11311-117C6	106.15	16.28
Natural Killer Cells, donor3	11387-118C1	92.76	15.28
Neural stem cells, donor1	11275-116H6	42.46	6.53
Neural stem cells, donor2	11352-117H2	44.29	17.33
Neurons, donor1	11494-119E9	46.65	15.93
Neurons, donor2	11574-120E8	48.44	16.51
Neurons, donor3	11655-122E8	57.55	19.73
Neutrophils, donor1	11233-116C9	53.82	21.34
Neutrophils, donor2	11314-117C9	34.79	5.80
Neutrophils, donor3	11390-118C4	68.41	15.27
Nucleus Pulposus Cell, donor1	11252-116F1	91.55	7.48
Nucleus Pulposus Cell, donor2	11409-118E5	64.80	7.49
Nucleus Pulposus Cell, donor3	11462-119B4	39.11	4.41
Olfactory epithelial cells, donor1	11933-125I7	45.98	4.54
Olfactory epithelial cells, donor2	11934-125I8	44.29	4.20
Olfactory epithelial cells, donor3	11935-125I9	44.38	3.97
Olfactory epithelial cells, donor4	11936-126A1	64.28	5.55
Oligodendrocyte - precursors, donor1	11496-119F2	33.10	6.02
Osteoblast - differentiated, donor1	11276-116H7	64.45	6.81
Osteoblast - differentiated, donor2	11353-117H3	38.87	3.43
Osteoblast - differentiated, donor3	11425-118G3	60.83	6.83
Osteoblast, donor1	11277-116H8	20.13	2.35
Osteoblast, donor2	11354-117H4	29.50	2.81
Osteoblast, donor3	11426-118G4	42.12	6.75
Pancreatic stromal cells, donor1	11249-116E7	48.01	2.78
Pericytes, donor1	11491-119E6	20.25	4.56
Pericytes, donor2	11571-120E5	18.79	5.21
Pericytes, donor3	11652-122E5	28.69	3.05
Perineurial Cells, donor1	11499-119F5	48.15	4.63
Perineurial Cells, donor2	11579-120F4	52.63	5.61
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	56.42	12.75
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	47.99	16.16
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	60.83	11.91
Placental Epithelial Cells, donor1	11278-116H9	18.18	1.91
Placental Epithelial Cells, donor2	11355-117H5	13.31	3.33
Placental Epithelial Cells, donor3	11427-118G5	19.63	2.36
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	21.52	4.43
Preadipocyte - breast, donor1	11467-119B9	27.95	2.44
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	12.66	2.48
Preadipocyte - breast, donor2	11328-117E5	36.92	3.60
Preadipocyte - omental, donor1	11468-119C1	38.36	3.30
Preadipocyte - omental, donor2	11329-117E6	26.62	3.49
Preadipocyte - omental, donor3	11403-118D8	23.64	4.15
Preadipocyte - perirenal, donor1	11469-119C2	16.73	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	17.81	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	32.05	4.60
Preadipocyte - subcutaneous, donor3	11428-118G6	40.53	5.28
Preadipocyte - visceral, donor1	11280-116I2	39.59	4.19
Preadipocyte - visceral, donor2	11357-117H7	23.01	4.14
Preadipocyte - visceral, donor3	11429-118G7	22.67	4.18
Prostate Epithelial Cells (polarized), donor1	11253-116F2	30.92	2.87
Prostate Epithelial Cells, donor2	11331-117E8	19.23	3.66
Prostate Epithelial Cells, donor3	11404-118D9	24.68	2.20
Prostate Stromal Cells, donor1	11254-116F3	25.86	2.62
Prostate Stromal Cells, donor2	11332-117E9	26.36	1.79
Prostate Stromal Cells, donor3	11405-118E1	40.98	4.59
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.56	3.28
Renal Cortical Epithelial Cells, donor2	11596-120H3	31.54	2.77
Renal Epithelial Cells, donor1	11517-119H5	16.74	3.04
Renal Epithelial Cells, donor2	11597-120H4	18.49	2.85
Renal Epithelial Cells, donor3	11678-122H4	40.44	2.75
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.74	3.40
Renal Glomerular Endothelial Cells, donor2	11594-120H1	23.18	4.04
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.08	5.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	0.00
Renal Mesangial Cells, donor1	11518-119H6	16.95	2.42
Renal Mesangial Cells, donor2	11598-120H5	33.86	3.76
Renal Mesangial Cells, donor3	11679-122H5	14.98	3.05
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	25.23	4.03
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	16.87	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	20.25	3.47
Retinal Pigment Epithelial Cells, donor0	11215-116A9	35.00	2.59
Retinal Pigment Epithelial Cells, donor1	11528-119I7	43.77	3.70
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	42.40	4.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	36.88	2.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	69.69	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	31.92	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	37.12	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	15.47	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	20.06	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	28.55	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	15.26	3.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	23.89	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	29.58	4.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	14.24	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	19.21	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	29.21	4.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.35	2.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	20.82	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	21.91	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	16.63	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.98	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	29.69	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	14.20	2.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	19.86	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	24.63	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.17	2.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	19.62	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	24.61	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	13.13	3.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	18.27	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	20.95	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	19.11	2.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	19.44	2.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	23.15	3.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	18.25	5.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	18.80	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	21.31	3.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	17.09	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.07	3.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.26	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	20.98	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	20.30	4.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	22.82	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.60	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	20.12	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.99	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	22.68	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	26.43	3.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	33.66	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	23.07	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	39.48	4.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	46.24	3.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	16.89	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	52.98	6.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	48.67	6.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	24.11	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	37.09	3.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	43.73	4.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	13.46	2.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.98	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.29	4.81
Schwann Cells, donor1	11498-119F4	12.79	2.26
Schwann Cells, donor2	11578-120F3	20.41	0.00
Schwann Cells, donor3	11659-122F3	31.55	2.85
Sebocyte, donor1	11220-116B5	15.34	3.29
Sebocyte, donor2	11301-117B5	16.08	2.76
Sebocyte, donor3	11378-118B1	24.53	3.50
Sertoli Cells, donor1	11255-116F4	26.51	8.28
Sertoli Cells, donor2	11333-117F1	25.42	8.47
Skeletal Muscle Cells, donor1	11281-116I3	44.34	4.05
Skeletal Muscle Cells, donor2	11358-117H8	15.90	5.06
Skeletal Muscle Cells, donor3	11430-118G8	14.21	4.18
Skeletal Muscle Cells, donor4	11451-119A2	25.61	3.77
Skeletal Muscle Cells, donor5	11455-119A6	27.80	4.91
Skeletal Muscle Cells, donor6	11459-119B1	25.70	4.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	63.63	3.53
Skeletal Muscle Satellite Cells, donor2	11321-117D7	60.50	5.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	41.27	3.47
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	33.36	3.12
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.75	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.51	1.93
Skin - palm, donor1	10286-104F7	69.84	21.49
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	13.26	1.73
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	14.72	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	16.23	1.69
Small Airway Epithelial Cells, donor1	11256-116F5	24.19	2.92
Small Airway Epithelial Cells, donor2	11334-117F2	17.86	3.94
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	19.66	5.29
Small Airway Epithelial Cells, donor3	11406-118E2	19.49	2.85
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	36.10	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	17.79	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	37.62	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	20.55	3.76
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.02	1.97
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.81	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	87.07	6.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	30.21	2.79
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	44.55	6.43
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	37.26	7.30
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	47.86	6.19
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.98	8.27
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	30.61	5.41
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.36	2.93
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	54.49	5.18
Smooth Muscle Cells - Carotid, donor1	11285-116I7	40.66	2.02
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.40	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	24.92	3.24
Smooth Muscle Cells - Colonic, donor2	11320-117D6	32.29	4.09
Smooth Muscle Cells - Colonic, donor3	11396-118D1	27.60	2.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.11	2.17
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	29.10	7.55
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.95	3.59
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.36	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	69.03	4.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	47.60	6.04
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	33.68	5.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.06	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	29.67	5.30
Smooth Muscle Cells - Prostate, donor1	11257-116F6	18.64	3.06
Smooth Muscle Cells - Prostate, donor2	11335-117F3	29.05	3.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	58.34	4.31
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	31.21	6.03
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	25.51	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	36.74	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	26.76	3.53
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.94	2.82
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.71	4.72
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	35.16	6.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	67.74	5.14
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	27.34	2.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	19.12	2.80
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.59	2.26
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	28.93	4.05
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	37.20	4.19
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.57	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	21.29	2.45
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.65	2.87
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.67	3.51
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	55.78	3.50
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	19.83	2.64
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	45.01	3.35
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	60.01	3.59
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	38.33	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	27.96	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	44.44	3.81
Smooth muscle cells - airway, control, donor2	11967-126D5	79.07	5.99
Smooth muscle cells - airway, control, donor3	11968-126D6	68.55	5.02
Smooth muscle cells - airway, control, donor4	11969-126D7	61.42	2.29
Synoviocyte, donor1	11291-117A4	44.44	4.04
Synoviocyte, donor2	11368-117I9	71.24	6.20
Synoviocyte, donor3	11440-118H9	43.79	5.36
Trabecular Meshwork Cells, donor1	11532-120A2	27.51	4.65
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	19.45	1.85
Tracheal Epithelial Cells, donor1	11292-117A5	18.78	2.65
Tracheal Epithelial Cells, donor2	11369-118A1	14.69	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	38.75	5.91
Urethra, donor2	10319-105A4	41.36	5.40
Urothelial Cells, donor1	11520-119H8	25.24	3.72
Urothelial Cells, donor2	11600-120H7	17.22	1.60
Urothelial Cells, donor3	11681-122H7	16.96	2.52
Urothelial cells, donor0	11216-116B1	37.45	4.68
Whole blood (ribopure), donor090309, donation1	12179-129A1	23.13	8.01
Whole blood (ribopure), donor090309, donation2	12180-129A2	25.73	7.15
Whole blood (ribopure), donor090309, donation3	12181-129A3	35.60	7.53
Whole blood (ribopure), donor090325, donation1	12176-128I7	48.90	9.30
Whole blood (ribopure), donor090325, donation2	12177-128I8	51.71	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	13.54	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	24.78	14.68
Whole blood (ribopure), donor090612, donation3	12184-129A6	36.52	10.04
Wilms' tumor cell line:G-401	10809-111A8	35.03	4.32
Wilms' tumor cell line:HFWT	10597-108E3	27.28	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	29.33	3.91
achilles tendon, donor2	10292-104G4	47.53	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	43.60	6.37
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	51.77	6.27
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	72.29	9.26
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	42.72	12.79
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	23.05	3.37
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	20.94	4.65
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	23.41	3.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	76.67	5.73
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	61.25	7.76
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	69.12	8.15
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	20.24	2.76
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	23.70	4.42
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	46.86	3.37
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	31.27	2.63
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	20.45	2.32
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	26.73	2.88
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.06	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	12.80	2.99
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	17.29	3.03
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	15.41	2.41
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	21.83	4.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	30.69	2.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	17.70	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	67.60	8.29
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	41.24	3.75
adenocarcinoma cell line:IM95m	10796-110I4	47.34	8.95
adipose tissue, adult, pool1	10010-101C1	44.36	3.88
adipose, donor1	10184-103D4	55.12	8.80
adipose, donor2	10185-103D5	41.36	12.98
adipose, donor3	10186-103D6	35.40	7.35
adipose, donor4	10187-103D7	51.14	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	58.39	6.63
adrenal gland, adult, pool1	10081-102A9	18.19	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	68.57	4.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	72.17	6.07
amniotic membrane cells, donor1	12235-129G3	34.31	7.88
amniotic membrane cells, donor2	12236-129G4	51.73	8.45
amniotic membrane cells, donor3	12237-129G5	29.75	5.01
amygdala - adult, donor10196	10167-103B5	45.06	17.79
amygdala, adult, donor10252	10151-102I7	35.08	15.82
amygdala, newborn, donor10223	10360-105E9	59.07	9.68
anaplastic carcinoma cell line:8305C	10428-106D5	72.20	5.48
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	57.36	2.87
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	116.24	15.70
aorta, adult, pool1	10052-101G7	62.57	9.41
appendix, adult	10189-103D9	38.81	6.21
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	88.39	5.50
artery, adult	10190-103E1	33.97	5.43
astrocytoma cell line:TM-31	10425-106D2	34.91	4.49
b cell line:RPMI1788	10427-106D4	57.84	3.27
basal cell carcinoma cell line:TE 354.T	10702-109G9	34.13	5.27
bile duct carcinoma cell line:HuCCT1	10432-106D9	60.73	4.37
bile duct carcinoma cell line:TFK-1	10496-107C1	27.62	4.69
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	43.06	3.36
bladder, adult, pool1	10011-101C2	77.90	10.43
blood, adult, pool1	10053-101G8	33.22	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	24.83	5.99
bone marrow, adult	10192-103E3	41.16	2.70
brain, adult, donor1	10084-102B3	66.63	28.70
brain, adult, pool1	10012-101C3	51.56	20.49
brain, fetal, pool1	10085-102B4	77.47	13.36
breast carcinoma cell line:MCF7	10482-107A5	49.89	7.27
breast carcinoma cell line:MDA-MB-453	10419-106C5	27.34	6.37
breast, adult, donor1	10080-102A8	48.61	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	12.45	3.18
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	33.09	4.02
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	25.09	3.45
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	42.85	9.93
carcinoid cell line:NCI-H1770	10703-109H1	58.77	12.22
carcinoid cell line:NCI-H727	10735-110B6	24.72	4.92
carcinoid cell line:SK-PN-DW	10719-109I8	60.84	6.97
carcinosarcoma cell line:JHUCS-1	10642-109A3	158.38	14.37
caudate nucleus - adult, donor10196	10177-103C6	46.05	13.82
caudate nucleus, adult, donor10252	10164-103B2	36.81	19.08
caudate nucleus, adult, donor10258	10379-105H1	38.97	26.74
caudate nucleus, newborn, donor10223	10354-105E3	49.08	7.32
cerebellum - adult, donor10196	10173-103C2	75.75	14.57
cerebellum, adult, donor10252	10166-103B4	54.87	17.51
cerebellum, adult, pool1	10083-102B2	64.16	17.94
cerebellum, newborn, donor10223	10357-105E6	89.67	14.11
cerebral meninges, adult	10188-103D8	78.16	22.69
cerebrospinal fluid, donor2	10294-104G6	27.04	8.77
cervical cancer cell line:D98-AH2	10552-107I3	77.93	4.31
cervical cancer cell line:ME-180	10553-107I4	61.65	5.30
cervix, adult, pool1	10013-101C4	88.09	8.50
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	41.94	7.80
chondrosarcoma cell line:SW 1353	10700-109G7	22.21	3.92
choriocarcinoma cell line:BeWo	10423-106C9	38.90	4.23
choriocarcinoma cell line:SCH	10785-110H2	53.84	4.56
choriocarcinoma cell line:T3M-3	10618-108G6	26.56	4.03
chorionic membrane cells, donor1	12238-129G6	25.93	2.85
chorionic membrane cells, donor2	12239-129G7	27.74	5.97
chorionic membrane cells, donor3	12240-129G8	18.68	3.85
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	38.37	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	30.74	4.61
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	48.15	7.39
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	35.70	3.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	33.86	2.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	28.51	2.85
chronic myelogenous leukemia cell line:K562	10454-106G4	23.85	4.71
chronic myelogenous leukemia cell line:KU812	10409-106B4	41.44	7.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	22.40	4.80
clear cell carcinoma cell line:TEN	10636-108I6	38.34	2.78
colon carcinoma cell line:CACO-2	10513-107D9	28.19	3.29
colon carcinoma cell line:COLO-320	10420-106C6	79.82	4.18
colon, adult, donor1	10082-102B1	47.60	7.14
colon, adult, pool1	10014-101C5	76.85	10.93
colon, fetal, donor1	10070-101I7	45.11	14.83
common myeloid progenitor CMP, donor1	12130-128D6	174.17	9.17
common myeloid progenitor CMP, donor2	12134-128E1	150.22	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	49.72	3.82
cord blood derived cell line:COBL-a 24h infection	10453-106G3	42.26	3.32
cord blood derived cell line:COBL-a untreated	10449-106F8	41.88	4.09
corpus callosum, adult, pool1	10042-101F6	42.23	10.17
cruciate ligament, donor2	10295-104G7	38.09	4.05
diaphragm, fetal, donor1	10069-101I6	36.12	8.03
diencephalon, adult	10193-103E4	36.00	12.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	64.75	5.74
ductal cell carcinoma cell line:KLM-1	10438-106E6	33.08	4.87
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	60.66	4.09
ductus deferens, adult	10196-103E7	42.36	9.47
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.25	5.89
dura mater, adult, donor1	10041-101F5	53.10	9.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	43.08	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	51.73	3.87
embryonic pancreas cell line:1B2C6	10604-108F1	32.06	6.17
embryonic pancreas cell line:1C3D3	10605-108F2	37.84	4.54
embryonic pancreas cell line:1C3IKEI	10606-108F3	35.51	3.40
embryonic pancreas cell line:2C6	10603-108E9	42.03	9.19
endometrial carcinoma cell line:OMC-2	10497-107C2	23.80	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	42.05	7.43
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	24.60	5.79
epidermoid carcinoma cell line:A431	10426-106D3	27.12	2.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	17.49	1.87
epididymis, adult	10197-103E8	57.56	9.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	42.93	5.85
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	50.73	5.90
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	25.82	4.06
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	33.66	3.84
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	26.10	3.81
esophagus, adult, pool1	10015-101C6	40.77	5.63
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	96.43	6.64
eye - muscle inferior rectus, donor1	10272-104E2	31.39	9.66
eye - muscle lateral, donor2	10298-104H1	14.73	0.00
eye - muscle medial, donor2	10299-104H2	29.76	7.44
eye - muscle superior, donor2	10297-104G9	21.78	6.88
eye - vitreous humor, donor1	10268-104D7	27.69	4.37
eye, fetal, donor1	10054-101G9	61.27	13.98
fibrosarcoma cell line:HT-1080	10758-110E2	29.62	2.44
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	62.44	4.75
frontal lobe, adult, pool1	10040-101F4	63.52	20.83
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	20.72	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	23.68	1.37
gall bladder, adult	10198-103E9	40.32	5.07
gamma delta positive T cells, donor1	11937-126A2	73.01	11.81
gamma delta positive T cells, donor2	11938-126A3	62.37	7.84
gastric adenocarcinoma cell line:MKN1	10614-108G2	45.41	6.34
gastric adenocarcinoma cell line:MKN45	10612-108F9	73.11	10.25
gastric cancer cell line:AZ521	10549-107H9	58.04	4.59
gastric cancer cell line:GSS	10560-108A2	51.25	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	73.56	8.22
giant cell carcinoma cell line:LU65	10487-107B1	15.72	1.26
giant cell carcinoma cell line:Lu99B	10433-106E1	77.96	5.74
glassy cell carcinoma cell line:HOKUG	10688-109F4	19.21	3.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	34.20	3.27
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.83	7.02
glioblastoma cell line:T98G	10485-107A8	61.04	4.75
glioma cell line:GI-1	10413-106B8	50.08	2.93
globus pallidus - adult, donor10196	10175-103C4	51.75	13.12
globus pallidus, adult, donor10252	10161-103A8	32.22	10.74
globus pallidus, adult, donor10258	10367-105F7	31.49	5.48
globus pallidus, newborn, donor10223	10364-105F4	49.03	4.80
granulocyte macrophage progenitor, donor1	12131-128D7	80.76	14.68
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	41.81	10.45
granulosa cell tumor cell line:KGN	10624-108H3	27.84	6.08
hIPS +CCl2, biol_rep1	14383-156B9	66.11	7.80
hIPS +CCl2, biol_rep2	14384-156C1	48.01	4.12
hIPS +CCl2, biol_rep3	14385-156C2	50.88	3.22
hIPS, biol_rep1	14380-156B6	35.93	1.44
hIPS, biol_rep2	14381-156B7	56.93	3.43
hIPS, biol_rep3	14382-156B8	32.00	11.03
hairy cell leukemia cell line:Mo	10712-109I1	75.57	6.61
heart - mitral valve, adult	10205-103F7	37.67	4.78
heart - pulmonic valve, adult	10206-103F8	34.78	8.37
heart - tricuspid valve, adult	10207-103F9	23.31	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	14.28	3.67
heart, adult, diseased, donor1	10051-101G6	21.29	2.13
heart, adult, pool1	10016-101C7	43.47	8.05
heart, fetal, pool1	10046-101G1	43.23	5.85
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.32	5.86
hepatoblastoma cell line:HuH-6	10633-108I3	33.30	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	22.65	5.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	19.30	4.37
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	20.92	3.74
hepatoma cell line:Li-7	10484-107A7	56.83	6.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	59.70	3.82
hippocampus - adult, donor10196	10169-103B7	28.39	21.77
hippocampus, adult, donor10252	10153-102I9	35.11	11.84
hippocampus, adult, donor10258	10374-105G5	41.33	12.95
hippocampus, newborn, donor10223	10363-105F3	41.59	11.28
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	89.11	4.27
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	65.39	3.73
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	93.69	3.30
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	54.69	5.64
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	39.76	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	49.35	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	49.63	9.05
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	46.96	8.83
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	42.96	5.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	47.36	5.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	44.20	6.75
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	57.90	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	75.43	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	67.80	4.91
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	110.84	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	51.93	6.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	40.12	5.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	53.97	4.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	51.43	10.17
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	39.56	8.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	62.33	7.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	43.27	7.02
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	35.71	6.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	54.11	5.68
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	59.12	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	53.35	4.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	93.10	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	35.91	4.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	33.26	5.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	45.09	4.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	29.48	4.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	33.87	8.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	51.82	5.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	32.98	6.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	37.86	6.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	48.39	5.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	67.14	3.86
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	88.24	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	81.46	3.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.23	6.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	71.57	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	50.30	4.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	41.05	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.41	3.62
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	45.91	4.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	41.85	5.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	46.07	4.85
immature langerhans cells, donor1	11904-125F5	53.03	9.20
immature langerhans cells, donor2	11905-125F6	38.81	6.34
insula, adult, pool1	10039-101F3	67.28	21.10
keratoacanthoma cell line:HKA-1	10791-110H8	28.29	7.80
kidney, adult, pool1	10017-101C8	29.14	6.71
kidney, fetal, pool1	10045-101F9	40.74	7.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	127.96	9.94
large cell lung carcinoma cell line:NCI-H460	10839-111E2	83.08	3.18
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	41.65	3.85
left atrium, adult, donor1	10079-102A7	31.06	6.54
left ventricle, adult, donor1	10078-102A6	23.26	6.07
leiomyoblastoma cell line:G-402	10721-110A1	33.65	6.02
leiomyoma cell line:10964C	10569-108B2	31.97	5.03
leiomyoma cell line:15242A	10570-108B3	41.30	7.61
leiomyoma cell line:15425	10571-108B4	31.57	5.34
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	54.37	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	86.30	7.44
liposarcoma cell line:KMLS-1	10782-110G8	54.52	5.15
liposarcoma cell line:SW 872	10726-110A6	22.78	5.12
liver, adult, pool1	10018-101C9	24.15	3.73
liver, fetal, pool1	10086-102B5	11.29	5.64
locus coeruleus - adult, donor10196	10182-103D2	44.04	12.10
locus coeruleus, adult, donor10252	10165-103B3	44.11	13.47
locus coeruleus, adult, donor10258	10375-105G6	39.22	10.16
locus coeruleus, newborn, donor10223	10362-105F2	41.22	4.21
lung adenocarcinoma cell line:A549	10499-107C4	35.29	2.91
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	35.72	4.88
lung, adult, pool1	10019-101D1	49.14	5.67
lung, fetal, donor1	10068-101I5	40.81	9.13
lung, right lower lobe, adult, donor1	10075-102A3	24.74	5.50
lymph node, adult, donor1	10077-102A5	29.82	4.73
lymphangiectasia cell line:DS-1	10727-110A7	53.26	4.82
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	247.67	28.53
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	69.66	7.65
mature adipocyte, donor1	12231-129F8	65.27	12.88
mature adipocyte, donor2	12232-129F9	67.86	13.07
mature adipocyte, donor3	12233-129G1	47.41	10.67
mature adipocyte, donor4	12234-129G2	49.75	11.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	35.26	6.91
medial frontal gyrus - adult, donor10196	10170-103B8	64.30	24.82
medial frontal gyrus, adult, donor10252	10150-102I6	49.65	12.14
medial frontal gyrus, adult, donor10258	10368-105F8	58.14	18.11
medial frontal gyrus, newborn, donor10223	10352-105E1	53.74	13.65
medial temporal gyrus - adult, donor10196	10183-103D3	63.28	23.96
medial temporal gyrus, adult, donor10252	10156-103A3	38.20	14.43
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	40.45	17.34
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	56.35	7.90
medulla oblongata - adult, donor10196	10174-103C3	40.89	8.44
medulla oblongata, adult, donor10252	10155-103A2	38.70	9.29
medulla oblongata, adult, pool1	10038-101F2	45.14	12.08
medulla oblongata, newborn, donor10223	10361-105F1	46.87	7.64
medulloblastoma cell line:D283 Med	10838-111E1	153.00	5.31
medulloblastoma cell line:ONS-76	10759-110E3	25.31	4.65
melanoma cell line:COLO 679	10514-107E1	17.39	2.59
melanoma cell line:G-361	10465-106H6	20.63	2.17
meningioma cell line:HKBMM	10691-109F7	47.04	5.97
merkel cell carcinoma cell line:MKL-1	10843-111E6	56.39	8.81
merkel cell carcinoma cell line:MS-1	10844-111E7	17.89	7.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.45	4.45
mesenchymal precursor cell - adipose, donor2	11748-123G2	34.72	5.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	25.67	2.90
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.61	3.37
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.78	5.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.79	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	28.66	4.81
mesenchymal precursor cell - cardiac, donor2	11753-123G7	25.99	4.03
mesenchymal precursor cell - cardiac, donor3	11754-123G8	21.62	3.32
mesenchymal precursor cell - cardiac, donor4	11755-123G9	20.93	4.05
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.64	2.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	30.63	3.29
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	22.97	4.43
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	28.28	4.89
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	33.28	4.90
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	34.51	5.39
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	23.07	3.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	19.15	3.88
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	15.94	5.45
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	23.46	4.78
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	24.07	5.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	44.92	3.68
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.18	3.15
mesenchymal stem cell line:Hu5/E18	10568-108B1	25.26	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	29.68	4.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	30.18	3.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	36.65	3.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	32.97	3.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	34.13	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	39.26	3.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	41.66	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	39.85	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	42.69	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	38.37	2.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	37.25	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	31.53	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	32.89	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	37.66	2.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	41.24	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	51.95	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	41.90	3.90
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	49.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	47.98	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	42.52	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	40.43	3.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	36.76	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	46.84	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	54.83	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	46.87	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	62.43	2.41
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	62.33	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	59.88	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	58.55	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	77.01	4.07
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	81.83	5.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	84.30	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	68.89	3.43
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	69.51	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	42.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	52.32	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	28.70	4.95
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	29.16	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	34.98	3.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	25.79	4.84
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	6.34
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.38	3.64
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	37.89	5.77
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	50.40	4.17
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	36.67	3.89
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	41.76	4.07
mesodermal tumor cell line:HIRS-BM	10696-109G3	45.65	10.83
mesothelioma cell line:ACC-MESO-1	10493-107B7	75.83	11.81
mesothelioma cell line:ACC-MESO-4	10494-107B8	32.67	7.41
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	44.80	3.60
mesothelioma cell line:Mero-25	10850-111F4	14.75	2.04
mesothelioma cell line:Mero-41	10851-111F5	22.25	3.67
mesothelioma cell line:Mero-48a	10852-111F6	33.66	4.65
mesothelioma cell line:Mero-82	10853-111F7	60.45	8.15
mesothelioma cell line:Mero-83	10854-111F8	54.13	4.26
mesothelioma cell line:Mero-84	10855-111F9	25.53	4.30
mesothelioma cell line:Mero-95	10856-111G1	26.29	3.11
mesothelioma cell line:NCI-H2052	10847-111F1	39.42	3.98
mesothelioma cell line:NCI-H226	10846-111E9	25.34	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	30.75	3.07
mesothelioma cell line:NCI-H28	10845-111E8	22.39	3.31
mesothelioma cell line:No36	10857-111G2	30.66	2.94
mesothelioma cell line:ONE58	10858-111G3	30.08	3.52
migratory langerhans cells, donor1	11901-125F2	24.95	5.18
migratory langerhans cells, donor2	11902-125F3	21.86	4.03
migratory langerhans cells, donor3	11903-125F4	43.97	5.38
mixed mullerian tumor cell line:HTMMT	10689-109F5	48.65	9.14
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	19.50	4.24
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	48.14	4.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	40.34	4.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	55.99	4.07
myeloma cell line:PCM6	10474-106I6	60.09	7.91
myxofibrosarcoma cell line:MFH-ino	10600-108E6	32.97	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	31.97	2.75
nasal epithelial cells, donor1, tech_rep1	12226-129F3	21.95	4.01
nasal epithelial cells, donor1, tech_rep2	12226-129F3	24.71	3.82
nasal epithelial cells, donor2	12227-129F4	29.26	2.76
neuroblastoma cell line:CHP-134	10508-107D4	183.82	13.80
neuroblastoma cell line:NB-1	10539-107G8	123.10	11.60
neuroblastoma cell line:NBsusSR	10607-108F4	38.59	11.18
neuroblastoma cell line:NH-12	10555-107I6	146.47	8.20
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	129.29	5.46
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	65.09	10.14
neuroectodermal tumor cell line:TASK1	10774-110F9	71.04	4.43
neuroepithelioma cell line:SK-N-MC	10728-110A8	53.40	15.89
neurofibroma cell line:Hs 53.T	10729-110A9	29.54	4.79
neutrophil PMN, donor1	12133-128D9	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	26.56
neutrophil PMN, donor3	12141-128E8	28.41	18.94
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	44.48	10.49
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	39.22	4.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	50.66	9.30
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	30.74	6.31
nucleus accumbens, adult, pool1	10037-101F1	56.24	17.44
occipital cortex - adult, donor10196	10172-103C1	59.75	20.60
occipital cortex, adult, donor10252	10163-103B1	45.62	9.93
occipital cortex, newborn, donor10223	10355-105E4	49.13	9.83
occipital lobe, adult, donor1	10076-102A4	59.04	22.04
occipital lobe, fetal, donor1	10073-102A1	114.14	40.34
occipital pole, adult, pool1	10036-101E9	48.33	15.85
olfactory region, adult	10195-103E6	44.32	11.27
optic nerve, donor1	10277-104E7	56.03	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.17	3.87
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	32.56	3.16
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	22.52	5.25
oral squamous cell carcinoma cell line:SAS	10544-107H4	45.05	6.24
osteoclastoma cell line:Hs 706.T	10704-109H2	36.45	4.12
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	123.33	5.61
osteosarcoma cell line:HS-Os-1	10558-107I9	52.59	4.03
ovary, adult, pool1	10020-101D2	74.69	8.12
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	26.95	3.67
pancreas, adult, donor1	10049-101G4	50.79	4.70
pancreatic carcinoma cell line:NOR-P1	10698-109G5	17.05	3.91
papillary adenocarcinoma cell line:8505C	10437-106E5	29.30	3.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.20	1.49
paracentral gyrus, adult, pool1	10035-101E8	53.54	17.30
parietal cortex, adult, donor10258	10373-105G4	38.90	11.74
parietal lobe - adult, donor10196	10171-103B9	40.44	15.99
parietal lobe, adult, donor10252	10157-103A4	40.76	13.40
parietal lobe, adult, pool1	10034-101E7	56.31	18.77
parietal lobe, fetal, donor1	10072-101I9	105.71	55.28
parietal lobe, newborn, donor10223	10356-105E5	66.17	11.59
parotid gland, adult	10199-103F1	28.98	2.47
penis, adult	10200-103F2	34.91	5.91
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	108.59	13.57
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.59	4.95
pineal gland - adult, donor10196	10179-103C8	42.57	9.68
pineal gland, adult, donor10252	10160-103A7	63.37	29.02
pineal gland, adult, donor10258	10377-105G8	40.76	13.80
pituitary gland - adult, donor10196	10180-103C9	62.73	13.15
pituitary gland, adult, donor10252	10162-103A9	88.60	16.68
pituitary gland, adult, donor10258	10378-105G9	87.68	16.17
placenta, adult, pool1	10021-101D3	24.08	3.76
plasma cell leukemia cell line:ARH-77	10840-111E3	51.25	4.11
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.18	4.51
pons, adult, pool1	10033-101E6	44.93	13.68
postcentral gyrus, adult, pool1	10032-101E5	61.20	18.31
promyelocytes/myelocytes PMC, donor1	12132-128D8	31.37	10.46
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	0.00
prostate cancer cell line:DU145	10490-107B4	27.38	3.79
prostate cancer cell line:PC-3	10439-106E7	28.31	3.63
prostate, adult, pool1	10022-101D4	60.13	6.89
putamen, adult, donor10196	10176-103C5	35.88	24.08
putamen, adult, donor10252	10152-102I8	64.70	19.61
putamen, adult, donor10258, tech_rep1	10372-105G3	36.06	14.21
putamen, adult, donor10258, tech_rep2	10372-105G3	28.99	14.74
putamen, newborn, donor10223	10365-105F5	38.98	3.00
rectal cancer cell line:TT1TKB	10469-106I1	101.54	4.95
rectum, fetal, donor1	10067-101I4	122.41	16.69
renal cell carcinoma cell line:OS-RC-2	10411-106B6	22.90	2.33
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	134.62	9.53
retina, adult, pool1	10030-101E3	50.49	15.51
retinoblastoma cell line:Y79	10475-106I7	85.47	5.46
rhabdomyosarcoma cell line:KYM-1	10787-110H4	24.96	3.93
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	73.67	7.59
sacrococcigeal teratoma cell line:HTST	10695-109G2	65.18	3.79
salivary acinar cells, donor1	11771-123I7	103.59	4.21
salivary acinar cells, donor2	11772-123I8	78.62	5.23
salivary acinar cells, donor3	11773-123I9	76.14	6.62
salivary gland, adult, pool1	10093-102C3	22.88	6.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	44.85	5.48
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	46.20	5.29
seminal vesicle, adult	10201-103F3	47.09	6.88
serous adenocarcinoma cell line:JHOS-2	10639-108I9	27.45	3.16
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	32.46	3.02
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	17.06	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	67.16	3.90
signet ring carcinoma cell line:Kato III	10436-106E4	33.27	3.54
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.93	2.58
skeletal muscle - soleus muscle, donor1	10282-104F3	34.76	20.57
skeletal muscle, adult, pool1	10023-101D5	61.29	13.07
skeletal muscle, fetal, donor1	10066-101I3	31.16	5.03
skin, adult, donor1	10074-102A2	20.36	0.00
skin, fetal, donor1	10065-101I2	57.44	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	42.36	18.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	30.89	3.78
small cell lung carcinoma cell line:DMS 144	10841-111E4	79.41	15.61
small cell lung carcinoma cell line:LK-2	10541-107H1	107.80	12.53
small cell lung carcinoma cell line:NCI-H82	10842-111E5	183.37	7.24
small cell lung carcinoma cell line:WA-hT	10562-108A4	21.57	3.70
small intestine, adult, pool1	10024-101D6	57.45	8.48
small intestine, fetal, donor1	10064-101I1	60.93	7.86
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	21.54	3.08
smooth muscle, adult, pool1	10048-101G3	54.28	8.01
somatostatinoma cell line:QGP-1	10781-110G7	69.69	9.65
spinal cord - adult, donor10196	10181-103D1	47.72	8.72
spinal cord, adult, donor10252	10159-103A6	47.71	6.31
spinal cord, adult, donor10258	10369-105F9	24.90	10.38
spinal cord, fetal, donor1	10056-101H2	54.28	19.51
spinal cord, newborn, donor10223	10359-105E8	63.37	9.18
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.54	3.88
spleen, adult, pool1	10025-101D7	26.98	4.19
spleen, fetal, pool1	10044-101F8	37.19	4.29
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	18.32	1.45
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	35.32	5.13
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	15.73	4.19
squamous cell carcinoma cell line:T3M-5	10616-108G4	59.03	3.91
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	32.87	5.07
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	30.08	4.66
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.73	4.65
stomach, fetal, donor1	10062-101H8	69.42	9.61
submaxillary gland, adult	10202-103F4	33.61	8.55
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	39.46	7.48
substantia nigra, adult, donor10258	10371-105G2	39.31	11.38
substantia nigra, newborn, donor10223	10358-105E7	40.98	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	25.68	8.71
temporal lobe, adult, pool1	10031-101E4	52.22	15.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	96.16	42.74
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	91.42	23.74
tenocyte, donor1	11763-123H8	54.46	5.59
tenocyte, donor2	11765-123I1	61.80	8.39
tenocyte, donor3	11768-123I4	38.18	6.30
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	55.92	7.14
teratocarcinoma cell line:NCR-G1	10798-110I6	34.38	3.08
teratocarcinoma cell line:PA-1	10807-111A6	67.88	3.56
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	41.51	5.46
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	63.53	6.05
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	78.74	7.85
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	21.17	5.21
testis, adult, pool1	10026-101D8	57.12	23.94
testis, adult, pool2	10096-102C6	57.29	47.36
thalamus - adult, donor10196	10168-103B6	64.03	9.94
thalamus, adult, donor10252	10154-103A1	35.79	9.06
thalamus, adult, donor10258, tech_rep1	10370-105G1	46.19	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	23.72	8.07
thalamus, newborn, donor10223	10366-105F6	43.72	5.18
throat, adult	10209-103G2	31.96	6.24
throat, fetal, donor1	10061-101H7	43.88	10.66
thymic carcinoma cell line:Ty-82	10803-111A2	80.09	11.73
thymus, adult, pool1	10027-101D9	43.34	10.64
thymus, fetal, pool1	10043-101F7	51.22	11.12
thyroid carcinoma cell line:KHM-5M	10776-110G2	42.02	4.39
thyroid carcinoma cell line:TCO-1	10783-110G9	75.71	6.15
thyroid, adult, pool1	10028-101E1	49.27	9.24
thyroid, fetal, donor1	10060-101H6	26.89	11.07
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	6.16
tongue, adult	10203-103F5	32.10	6.51
tongue, fetal, donor1	10059-101H5	42.96	10.25
tonsil, adult, pool1	10047-101G2	42.17	7.51
trachea, adult, pool1	10029-101E2	33.29	6.05
trachea, fetal, donor1	10058-101H4	43.09	7.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	25.15	3.54
transitional-cell carcinoma cell line:5637	10418-106C4	22.39	2.33
transitional-cell carcinoma cell line:JMSU1	10492-107B6	65.18	6.42
tridermal teratoma cell line:HGRT	10694-109G1	38.05	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	64.00	4.74
umbilical cord, fetal, donor1	10057-101H3	29.21	6.26
uterus, adult, pool1	10100-102D1	48.80	7.85
uterus, fetal, donor1	10055-101H1	92.15	11.77
vagina, adult	10204-103F6	39.42	2.58
vein, adult	10191-103E2	38.36	6.58
xeroderma pigentosum b cell line:XPL 17	10563-108A5	42.46	4.01